1. Home
  2. SNCR vs IKNA Comparison

SNCR vs IKNA Comparison

Compare SNCR & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNCR
  • IKNA
  • Stock Information
  • Founded
  • SNCR 2000
  • IKNA 2016
  • Country
  • SNCR United States
  • IKNA United States
  • Employees
  • SNCR N/A
  • IKNA N/A
  • Industry
  • SNCR EDP Services
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNCR Technology
  • IKNA Health Care
  • Exchange
  • SNCR Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • SNCR 137.5M
  • IKNA 83.0M
  • IPO Year
  • SNCR 2006
  • IKNA 2021
  • Fundamental
  • Price
  • SNCR $11.25
  • IKNA $1.68
  • Analyst Decision
  • SNCR
  • IKNA Buy
  • Analyst Count
  • SNCR 0
  • IKNA 2
  • Target Price
  • SNCR N/A
  • IKNA $3.00
  • AVG Volume (30 Days)
  • SNCR 81.2K
  • IKNA 41.6K
  • Earning Date
  • SNCR 11-12-2024
  • IKNA 11-07-2024
  • Dividend Yield
  • SNCR N/A
  • IKNA N/A
  • EPS Growth
  • SNCR N/A
  • IKNA N/A
  • EPS
  • SNCR N/A
  • IKNA N/A
  • Revenue
  • SNCR $167,615,000.00
  • IKNA $1,844,000.00
  • Revenue This Year
  • SNCR $7.76
  • IKNA N/A
  • Revenue Next Year
  • SNCR $5.83
  • IKNA N/A
  • P/E Ratio
  • SNCR N/A
  • IKNA N/A
  • Revenue Growth
  • SNCR 33.39
  • IKNA N/A
  • 52 Week Low
  • SNCR $2.70
  • IKNA $1.02
  • 52 Week High
  • SNCR $15.46
  • IKNA $4.63
  • Technical
  • Relative Strength Index (RSI)
  • SNCR 43.11
  • IKNA 51.57
  • Support Level
  • SNCR $10.45
  • IKNA $1.68
  • Resistance Level
  • SNCR $11.44
  • IKNA $1.78
  • Average True Range (ATR)
  • SNCR 0.57
  • IKNA 0.04
  • MACD
  • SNCR -0.06
  • IKNA 0.00
  • Stochastic Oscillator
  • SNCR 31.58
  • IKNA 36.36

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: